51 results
Page 2 of 3
6-K
EX-1
7lsvafssc dr9
30 Oct 20
BioLineRx Announces Positive Results from Interim Analysis of
7:09am
6-K
EX-99
1s1q3d gs
30 Jan 20
Extraordinary General Meeting of Shareholders
7:00am
6-K
EX-99.1
1j8j3im35km0 b4r67n
4 Feb 19
Current report (foreign)
4:30pm
20-F/A
EX-4.33
fm1frl28 8mb7
31 May 16
Annual report (foreign) (amended)
12:00am
20-F/A
cnu rf5f4nhhhij2x
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
x0l26lown5r6pq bgw
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
v2amh
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
306lgqlhqnknqz
5 Mar 15
Current report (foreign)
12:00am
424B2
0trpbvk7o2pzimce1
13 Jun 14
Prospectus for primary offering
12:00am
F-3
hku2l 4fs
30 May 14
Shelf registration (foreign)
12:00am
424B5
cy5rjx18f cfata
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
2ebfx4w6bcvlw6cj9i28
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
bpbtje eglxj
3 Mar 14
Current report (foreign)
12:00am